Baseline susceptibility of primary HIV-2 to entry inhibitors.

This is the author’s version of a work accepted for publication by International Medical Press. Changes resulting from the publishing process, including peer review, editing and formatting, might not be reflected in this document. A definitive version was published in Antiviral Therapy, 17 (3): 565-570, January © 2012 International Medical Press.